Soluble Guanylate Cyclase Stimulator [EPC]

Soluble Guanylate Cyclase Stimulator [EPC] was reported 33867 times

These side effects are most commonly reported by patients taking drugs of the Soluble Guanylate Cyclase Stimulator [EPC] class:

# Drug class Count
0 DYSPNOEA 5830
1 DEATH 5519
2 HEADACHE 4590
3 NAUSEA 3850
4 DIZZINESS 3654
5 DIARRHOEA 3598
6 HYPOTENSION 3564
7 FATIGUE 3054
8 HOSPITALISATION 2346
9 VOMITING 2161
10 COUGH 1838
11 OEDEMA PERIPHERAL 1819
12 PNEUMONIA 1790
13 FLUID RETENTION 1775
14 MALAISE 1722
15 PERIPHERAL SWELLING 1677
16 DYSPNOEA EXERTIONAL 1585
17 ASTHENIA 1425
18 CHEST PAIN 1383
19 PAIN IN EXTREMITY 1337
20 PAIN 1304
21 OXYGEN SATURATION DECREASED 1274
22 DYSPEPSIA 1268
23 FALL 1234
24 WEIGHT DECREASED 1211
25 DECREASED APPETITE 1193
26 PULMONARY ARTERIAL HYPERTENSION 1130
27 PAIN IN JAW 1092
28 SYNCOPE 1075
29 OEDEMA 1072
30 WEIGHT INCREASED 1011
31 CONSTIPATION 969
32 FEELING ABNORMAL 956
33 ABDOMINAL DISCOMFORT 941
34 PULMONARY HYPERTENSION 937
35 ARTHRALGIA 932
36 BLOOD PRESSURE DECREASED 932
37 EPISTAXIS 902
38 ABDOMINAL PAIN UPPER 887
39 NASAL CONGESTION 850
40 ABDOMINAL DISTENSION 837
41 ANAEMIA 820
42 PALPITATIONS 813
43 NASOPHARYNGITIS 798
44 FLUSHING 756
45 GASTROOESOPHAGEAL REFLUX DISEASE 742
46 CONDITION AGGRAVATED 734
47 BACK PAIN 701
48 INFUSION SITE PAIN 687
49 OFF LABEL USE 687
50 PYREXIA 683
51 PRODUCT DOSE OMISSION ISSUE 664
52 LOSS OF CONSCIOUSNESS 658
53 CHEST DISCOMFORT 654
54 ABDOMINAL PAIN 627
55 CARDIAC FAILURE 605
56 HEART RATE INCREASED 605
57 JOINT SWELLING 596
58 MYALGIA 593
59 SWELLING 577
60 DEHYDRATION 565
61 HAEMOGLOBIN DECREASED 558
62 HAEMOPTYSIS 540
63 INSOMNIA 529
64 RIGHT VENTRICULAR FAILURE 498
65 CARDIAC FAILURE CONGESTIVE 497
66 URINARY TRACT INFECTION 492
67 PRODUCTIVE COUGH 488
68 ANXIETY 482
69 DRUG INEFFECTIVE 471
70 HYPOXIA 469
71 INFLUENZA 460
72 RASH 453
73 FLUID OVERLOAD 436
74 GASTROINTESTINAL DISORDER 435
75 ATRIAL FIBRILLATION 423
76 MUSCLE SPASMS 423
77 PRURITUS 407
78 GASTROINTESTINAL HAEMORRHAGE 393
79 THERAPY NON-RESPONDER 389
80 INFUSION SITE ERYTHEMA 385
81 RESPIRATORY FAILURE 379
82 GAIT DISTURBANCE 378
83 UNEVALUABLE EVENT 378
84 HAEMORRHAGE 373
85 LUNG DISORDER 369
86 PRODUCT USE ISSUE 367
87 PULMONARY OEDEMA 363
88 DRUG DOSE OMISSION 361
89 SOMNOLENCE 358
90 ILLNESS 356
91 SEPSIS 345
92 COVID-19 341
93 OROPHARYNGEAL PAIN 336
94 DRUG INTOLERANCE 334
95 ASCITES 330
96 GENERAL PHYSICAL HEALTH DETERIORATION 327
97 CARDIAC DISORDER 316
98 MIGRAINE 311
99 RENAL FAILURE 309
100 PERICARDIAL EFFUSION 308
101 PLEURAL EFFUSION 304
102 ERYTHEMA 296
103 BLOOD POTASSIUM DECREASED 293
104 ACUTE KIDNEY INJURY 292
105 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 292
106 DIZZINESS POSTURAL 289
107 SINUSITIS 286
108 TRANSFUSION 280
109 HYPERTENSION 277
110 CHILLS 276
111 SEASONAL ALLERGY 276
112 THROAT IRRITATION 275
113 PRESYNCOPE 274
114 CONTUSION 273
115 BRONCHITIS 268
116 INFECTION 263
117 THROMBOSIS 262
118 TACHYCARDIA 261
119 RHINORRHOEA 255
120 TREMOR 255
121 PULMONARY EMBOLISM 253
122 INCORRECT DOSE ADMINISTERED 251
123 CELLULITIS 249
124 FLATULENCE 249
125 PRODUCT DOSE OMISSION 246
126 ACUTE RESPIRATORY FAILURE 244
127 PLATELET COUNT DECREASED 244
128 VISION BLURRED 241
129 BLOOD PRESSURE DIASTOLIC DECREASED 239
130 BLOOD PRESSURE ABNORMAL 238
131 BLOOD PRESSURE SYSTOLIC DECREASED 237
132 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 234
133 DISEASE PROGRESSION 234
134 DEVICE DISLOCATION 230
135 MEMORY IMPAIRMENT 228
136 INFUSION SITE SWELLING 227
137 HAEMATOCHEZIA 226
138 MUSCULAR WEAKNESS 224
139 DEPRESSION 223
140 CATHETERISATION CARDIAC 218
141 HYPOAESTHESIA 213
142 CONFUSIONAL STATE 212
143 HEAD INJURY 211
144 ADVERSE EVENT 209
145 RENAL DISORDER 207
146 NECK PAIN 206
147 GASTRIC DISORDER 204
148 HYPERVOLAEMIA 204
149 RENAL IMPAIRMENT 201
150 DEVICE RELATED INFECTION 200
151 DERMATITIS CONTACT 195
152 HYPERSENSITIVITY 191
153 WHEEZING 191
154 BLOOD PRESSURE INCREASED 188
155 INFLUENZA LIKE ILLNESS 184
156 SWELLING FACE 184
157 ADVERSE DRUG REACTION 183
158 INJECTION SITE PAIN 183
159 RECTAL HAEMORRHAGE 182
160 OXYGEN CONSUMPTION INCREASED 180
161 PULMONARY THROMBOSIS 180
162 VASCULAR DEVICE INFECTION 180
163 LETHARGY 179
164 PULMONARY ARTERIAL PRESSURE INCREASED 179
165 PARAESTHESIA 176
166 UPPER RESPIRATORY TRACT INFECTION 176
167 TREATMENT NONCOMPLIANCE 173
168 INFUSION SITE INFECTION 171
169 BALANCE DISORDER 170
170 MUSCULOSKELETAL PAIN 170
171 DEVICE ISSUE 169
172 DYSPHAGIA 169
173 HOT FLUSH 168
174 THERAPY CESSATION 167
175 HYPERHIDROSIS 166
176 SURGERY 166
177 INTESTINAL OBSTRUCTION 164
178 RETCHING 164
179 THERAPY INTERRUPTED 164
180 HAEMATEMESIS 160
181 THERAPY CHANGE 159
182 INFUSION SITE HAEMORRHAGE 158
183 VISUAL IMPAIRMENT 154
184 RESPIRATORY TRACT CONGESTION 149
185 LUNG TRANSPLANT 148
186 NEUROPATHY PERIPHERAL 146
187 DIALYSIS 145
188 GOUT 145
189 DRY MOUTH 143
190 DYSPNOEA AT REST 143
191 CATHETER SITE ERYTHEMA 142
192 DEVICE OCCLUSION 142
193 SINUS CONGESTION 142
194 STRESS 142
195 COMPLICATION ASSOCIATED WITH DEVICE 140
196 INTERNAL HAEMORRHAGE 140
197 SINUS DISORDER 140
198 CARDIAC ARREST 139
199 DEVICE LEAKAGE 139
200 FEELING HOT 139
201 VERTIGO 138
202 ARRHYTHMIA 135
203 DRUG HYPERSENSITIVITY 134
204 DYSPHONIA 134
205 BLOOD CREATININE INCREASED 132
206 BLOOD PRESSURE FLUCTUATION 131
207 INTENTIONAL PRODUCT USE ISSUE 131
208 ALOPECIA 130
209 GENERALISED OEDEMA 130
210 INTERNATIONAL NORMALISED RATIO INCREASED 130
211 LOCALISED OEDEMA 128
212 ARTHRITIS 126
213 URTICARIA 125
214 CLOSTRIDIUM DIFFICILE INFECTION 123
215 RESPIRATORY DISTRESS 123
216 TINNITUS 120
217 HEART RATE DECREASED 118
218 RALES 118
219 CEREBROVASCULAR ACCIDENT 117
220 MYOCARDIAL INFARCTION 117
221 CATHETER SITE PAIN 116
222 NERVOUSNESS 116
223 LIMB INJURY 115
224 DEVICE MALFUNCTION 114
225 BLOOD IRON DECREASED 113
226 HEAD DISCOMFORT 113
227 SEIZURE 113
228 DECREASED ACTIVITY 112
229 DEVICE INFUSION ISSUE 111
230 FEELING COLD 111
231 POLLAKIURIA 111
232 INJECTION SITE ERYTHEMA 110
233 SEPTIC SHOCK 110
234 GASTROENTERITIS VIRAL 109
235 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 109
236 MOBILITY DECREASED 107
237 PRODUCT USE IN UNAPPROVED INDICATION 106
238 GAIT INABILITY 105
239 INCORRECT PRODUCT ADMINISTRATION DURATION 105
240 FEEDING DISORDER 104
241 VIRAL INFECTION 104
242 DYSGEUSIA 103
243 LIVER DISORDER 103
244 BRAIN NATRIURETIC PEPTIDE INCREASED 102
245 INFUSION SITE DISCHARGE 102
246 PULMONARY CONGESTION 102
247 INFLAMMATION 101
248 SYSTEMIC LUPUS ERYTHEMATOSUS 101
249 GASTRITIS 100
250 BURNING SENSATION 99
251 ASTHMA 98
252 BONE PAIN 98
253 CATHETER MANAGEMENT 98
254 DRUG INTERACTION 98
255 HYPERSOMNIA 98
256 FAECES DISCOLOURED 97
257 HYPOKALAEMIA 97
258 CATHETER SITE HAEMORRHAGE 96
259 INFUSION SITE PRURITUS 96
260 OXYGEN THERAPY 96
261 RESPIRATORY TRACT INFECTION 96
262 BLOOD COUNT ABNORMAL 95
263 DEPRESSED MOOD 95
264 RASH PRURITIC 95
265 PRODUCT AVAILABILITY ISSUE 94
266 HOSPICE CARE 93
267 DEVICE FAILURE 92
268 LIMB DISCOMFORT 92
269 NEPHROLITHIASIS 91
270 SLEEP DISORDER 91
271 BLOOD GLUCOSE INCREASED 90
272 CATHETER SITE PRURITUS 90
273 LOCALISED INFECTION 90
274 PULMONARY ENDARTERECTOMY 90
275 ATRIAL FLUTTER 89
276 CENTRAL VENOUS CATHETERISATION 89
277 DIVERTICULITIS 89
278 SCLERODERMA 89
279 BLOOD GLUCOSE DECREASED 88
280 EXERCISE TOLERANCE DECREASED 88
281 ERUCTATION 87
282 HERPES ZOSTER 87
283 SMALL INTESTINAL OBSTRUCTION 86
284 WEIGHT FLUCTUATION 86
285 CATARACT 85
286 HEART RATE IRREGULAR 85
287 HYPOACUSIS 85
288 INFUSION SITE INDURATION 85
289 IRON DEFICIENCY ANAEMIA 85
290 MELAENA 85
291 PRODUCT PRESCRIBING ISSUE 85
292 INTERSTITIAL LUNG DISEASE 84
293 DRY SKIN 83
294 CARDIAC FAILURE ACUTE 82
295 DISCOMFORT 82
296 EYE SWELLING 82
297 SKIN DISCOLOURATION 82
298 CARDIOMEGALY 81
299 EAR INFECTION 81
300 CHRONIC KIDNEY DISEASE 80
301 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 80
302 ORTHOSTATIC HYPOTENSION 80
303 RESPIRATORY DISORDER 80
304 THROMBOCYTOPENIA 80
305 BLOOD PRESSURE SYSTOLIC INCREASED 79
306 CHOKING 79
307 HAEMORRHOIDS 79
308 GASTROENTERITIS 78
309 HIP FRACTURE 78
310 LABORATORY TEST ABNORMAL 78
311 ROAD TRAFFIC ACCIDENT 78
312 SPUTUM DISCOLOURED 78
313 INTENTIONAL DOSE OMISSION 77
314 MENTAL STATUS CHANGES 77
315 NEOPLASM MALIGNANT 77
316 NEURALGIA 77
317 EXTRA DOSE ADMINISTERED 76
318 INFUSION SITE REACTION 76
319 INFUSION SITE WARMTH 76
320 SPEECH DISORDER 76
321 WHITE BLOOD CELL COUNT DECREASED 76
322 FREQUENT BOWEL MOVEMENTS 75
323 MULTIPLE ALLERGIES 75
324 SNEEZING 75
325 CATHETER SITE INFECTION 74
326 DEVICE ALARM ISSUE 74
327 DEVICE USE ERROR 74
328 MUSCULOSKELETAL STIFFNESS 74
329 POOR QUALITY SLEEP 74
330 STAPHYLOCOCCAL INFECTION 74
331 BLOOD SODIUM DECREASED 72
332 CATHETER SITE DISCHARGE 72
333 INTENTIONAL PRODUCT MISUSE 72
334 HAEMATOMA 71
335 HEPATIC CIRRHOSIS 71
336 NASAL DRYNESS 71
337 SLEEP APNOEA SYNDROME 70
338 CARDIAC OPERATION 69
339 DYSURIA 69
340 PALLOR 69
341 UNDERDOSE 69
342 CONCOMITANT DISEASE AGGRAVATED 68
343 OCULAR HYPERAEMIA 68
344 OVERDOSE 68
345 CARDIO-RESPIRATORY ARREST 67
346 FAECES SOFT 67
347 TRANSPLANT EVALUATION 67
348 EAR DISCOMFORT 66
349 ILL-DEFINED DISORDER 66
350 INFUSION SITE IRRITATION 66
351 SICKLE CELL ANAEMIA WITH CRISIS 66
352 GALLBLADDER DISORDER 65
353 LACRIMATION INCREASED 65
354 NO ADVERSE EVENT 65
355 RED BLOOD CELL COUNT DECREASED 65
356 VAGINAL HAEMORRHAGE 65
357 DEVICE MAINTENANCE ISSUE 64
358 HAEMATOCRIT DECREASED 64
359 HYPOPHAGIA 64
360 EATING DISORDER 63
361 MUSCULOSKELETAL CHEST PAIN 63
362 PRODUCT ADMINISTRATION INTERRUPTED 63
363 ANGIOPLASTY 62
364 PANIC ATTACK 62
365 CARDIOGENIC SHOCK 61
366 BREATH SOUNDS ABNORMAL 60
367 CEREBRAL HAEMORRHAGE 60
368 CHOLELITHIASIS 60
369 DIABETES MELLITUS 60
370 EAR PAIN 60
371 PANCREATITIS 60
372 REHABILITATION THERAPY 60
373 CYSTITIS 59
374 HAEMOGLOBIN INCREASED 59
375 HERNIA 59
376 INJECTION SITE HAEMORRHAGE 59
377 BLOOD URINE PRESENT 58
378 EMERGENCY CARE 58
379 PULMONARY PAIN 58
380 RESPIRATION ABNORMAL 58
381 RIB FRACTURE 58
382 BLISTER 57
383 ENDARTERECTOMY 57
384 LOWER RESPIRATORY TRACT INFECTION 57
385 COLITIS 56
386 DEAFNESS 56
387 DISORIENTATION 56
388 JOINT INJURY 56
389 LUNG NEOPLASM MALIGNANT 56
390 MULTIPLE ORGAN DYSFUNCTION SYNDROME 56
391 SKIN ULCER 56
392 OXYGEN SATURATION ABNORMAL 55
393 POST PROCEDURAL COMPLICATION 55
394 PRODUCT SUPPLY ISSUE 55
395 SECRETION DISCHARGE 55
396 ALANINE AMINOTRANSFERASE INCREASED 54
397 AMNESIA 54
398 ASPARTATE AMINOTRANSFERASE INCREASED 54
399 BRADYCARDIA 54
400 DEEP VEIN THROMBOSIS 54
401 FACE OEDEMA 54
402 GASTRIC HAEMORRHAGE 54
403 ABNORMAL LOSS OF WEIGHT 53
404 ACCIDENTAL OVERDOSE 53
405 CYANOSIS 53
406 HALLUCINATION 53
407 TERMINAL STATE 53
408 THERAPY PARTIAL RESPONDER 53
409 WALKING DISTANCE TEST ABNORMAL 53
410 BEDRIDDEN 52
411 DEVICE BREAKAGE 52
412 DIZZINESS EXERTIONAL 52
413 HYPONATRAEMIA 52
414 INJECTION SITE SWELLING 52
415 RHEUMATOID ARTHRITIS 52
416 UPPER GASTROINTESTINAL HAEMORRHAGE 52
417 BACTERIAL INFECTION 51
418 CATHETER SITE SWELLING 51
419 EYE PAIN 51
420 GINGIVAL BLEEDING 51
421 MEDICAL PROCEDURE 51
422 PULMONARY HAEMORRHAGE 51
423 SUPRAVENTRICULAR TACHYCARDIA 51
424 CARDIAC FAILURE CHRONIC 50
425 DYSSTASIA 50
426 INJECTION SITE PRURITUS 50
427 TASTE DISORDER 50
428 TOOTHACHE 50
429 COLD SWEAT 49
430 DISEASE COMPLICATION 49
431 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49
432 MOOD ALTERED 49
433 RASH ERYTHEMATOUS 49
434 SLUGGISHNESS 49
435 ANGINA PECTORIS 48
436 HIATUS HERNIA 48
437 KIDNEY INFECTION 48
438 MUSCULOSKELETAL DISCOMFORT 48
439 PANCYTOPENIA 48
440 SKIN IRRITATION 48
441 UNRESPONSIVE TO STIMULI 48
442 UPPER-AIRWAY COUGH SYNDROME 48
443 ABNORMAL WEIGHT GAIN 47
444 CARDIAC PACEMAKER INSERTION 47
445 HAEMORRHOIDAL HAEMORRHAGE 47
446 HEPATIC FUNCTION ABNORMAL 47
447 INFUSION SITE RASH 47
448 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47
449 WHITE BLOOD CELL COUNT INCREASED 47
450 HYPERTHYROIDISM 46
451 INCREASED TENDENCY TO BRUISE 46
452 MUSCLE TIGHTNESS 46
453 PNEUMONIA ASPIRATION 46
454 PNEUMOTHORAX 46
455 POLYURIA 46
456 RESTLESS LEGS SYNDROME 46
457 IMPAIRED GASTRIC EMPTYING 45
458 INJECTION SITE INFECTION 45
459 FEELING JITTERY 44
460 HYPOGLYCAEMIA 44
461 INTRA-ABDOMINAL FLUID COLLECTION 44
462 IRRITABLE BOWEL SYNDROME 44
463 LEFT VENTRICULAR FAILURE 44
464 LUNG INFECTION 44
465 OXYGEN SUPPLEMENTATION 44
466 UPPER LIMB FRACTURE 44
467 URINARY RETENTION 44
468 URINE OUTPUT DECREASED 44
469 AGITATION 43
470 BLOOD POTASSIUM INCREASED 43
471 CHOKING SENSATION 43
472 GASTRIC ULCER 43
473 INFUSION SITE DISCOMFORT 43
474 IRRITABILITY 43
475 SCIATICA 43
476 WOUND 43
477 AGEUSIA 42
478 BENDOPNOEA 42
479 BLOOD MAGNESIUM DECREASED 42
480 CANDIDA INFECTION 42
481 CARDIAC FLUTTER 42
482 CATHETER PLACEMENT 42
483 LYMPHADENOPATHY 42
484 PULMONARY FIBROSIS 42
485 PURULENT DISCHARGE 42
486 SKIN LACERATION 42
487 SUBDURAL HAEMATOMA 42
488 TOOTH EXTRACTION 42
489 BLOOD TEST ABNORMAL 41
490 EYE DISORDER 41
491 EYE PRURITUS 41
492 HEPATIC FAILURE 41
493 PARACENTESIS 41
494 PNEUMONITIS 41
495 PRODUCT DOSE OMISSION IN ERROR 41
496 RESPIRATORY SYNCYTIAL VIRUS INFECTION 41
497 SHOCK 41
498 ANKLE FRACTURE 40
499 DEVICE POWER SOURCE ISSUE 40
500 EYE HAEMORRHAGE 40
501 INFUSION SITE INFLAMMATION 40
502 RIGHT VENTRICULAR DYSFUNCTION 40
503 THROAT TIGHTNESS 40
504 URINARY INCONTINENCE 40
505 BREAST CANCER 39
506 COVID-19 PNEUMONIA 39
507 FOOD POISONING 39
508 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 39
509 OROPHARYNGEAL DISCOMFORT 39
510 THERAPEUTIC RESPONSE DECREASED 39
511 TRICUSPID VALVE INCOMPETENCE 39
512 ABDOMINAL PAIN LOWER 38
513 ACCIDENT 38
514 BLOOD UREA INCREASED 38
515 COMA 38
516 FLANK PAIN 38
517 FUNGAL INFECTION 38
518 HAEMATURIA 38
519 HEART RATE ABNORMAL 38
520 PHOTOPHOBIA 38
521 THYROID DISORDER 38
522 ASPIRATION 37
523 BLOOD BILIRUBIN INCREASED 37
524 CATHETER SITE RASH 37
525 DEVICE CONNECTION ISSUE 37
526 DEVICE DIFFICULT TO USE 37
527 HEPATIC ENZYME INCREASED 37
528 MENTAL IMPAIRMENT 37
529 MOUTH HAEMORRHAGE 37
530 PARANASAL SINUS HYPERSECRETION 37
531 POST PROCEDURAL HAEMORRHAGE 37
532 PULMONARY VENO-OCCLUSIVE DISEASE 37
533 CIRCULATORY COLLAPSE 36
534 CONTRAINDICATED PRODUCT ADMINISTERED 36
535 FOOT FRACTURE 36
536 JOINT STIFFNESS 36
537 MENORRHAGIA 36
538 ORTHOPNOEA 36
539 RESPIRATORY ARREST 36
540 TRANSIENT ISCHAEMIC ATTACK 36
541 BACTERAEMIA 35
542 DISTURBANCE IN ATTENTION 35
543 DRUG TITRATION ERROR 35
544 FULL BLOOD COUNT DECREASED 35
545 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 35
546 OESOPHAGITIS 35
547 PROCEDURAL COMPLICATION 35
548 PROCEDURAL PAIN 35
549 PULMONARY ALVEOLAR HAEMORRHAGE 35
550 ARTHROPATHY 34
551 DRY THROAT 34
552 DYSARTHRIA 34
553 HYPERKALAEMIA 34
554 INJURY 34
555 PACKED RED BLOOD CELL TRANSFUSION 34
556 RASH MACULAR 34
557 WRIST FRACTURE 34
558 COLON CANCER 33
559 CRYING 33
560 ELECTROLYTE IMBALANCE 33
561 HEPATOMEGALY 33
562 LIGAMENT SPRAIN 33
563 LIVER FUNCTION TEST INCREASED 33
564 LOWER LIMB FRACTURE 33
565 MUSCLE STRAIN 33
566 NASAL DISCOMFORT 33
567 SKIN EXFOLIATION 33
568 UNINTENTIONAL MEDICAL DEVICE REMOVAL 33
569 CHOLECYSTECTOMY 32
570 COAGULOPATHY 32
571 DEVICE WIRELESS COMMUNICATION ISSUE 32
572 DIASTOLIC HYPOTENSION 32
573 DRUG DOSE TITRATION NOT PERFORMED 32
574 ENCEPHALOPATHY 32
575 STENT PLACEMENT 32
576 VASODILATATION 32
577 ASPHYXIA 31
578 BACK INJURY 31
579 BRAIN FOG 31
580 CARDIAC ABLATION 31
581 CHRONIC RESPIRATORY FAILURE 31
582 DYSKINESIA 31
583 OSTEOARTHRITIS 31
584 PULMONARY MASS 31
585 ULCER 31
586 ATELECTASIS 30
587 DEMENTIA 30
588 DIARRHOEA HAEMORRHAGIC 30
589 DRUG TOLERANCE DECREASED 30
590 FEMUR FRACTURE 30
591 HYSTERECTOMY 30
592 INFUSION SITE ABSCESS 30
593 LYMPHOEDEMA 30
594 MIDDLE INSOMNIA 30
595 PERIPHERAL COLDNESS 30
596 PRODUCT ADMINISTRATION ERROR 30
597 RASH GENERALISED 30
598 RIGHT VENTRICULAR DILATATION 30
599 SARS-COV-2 TEST POSITIVE 30
600 SKIN ABRASION 30
601 APHASIA 29
602 CLOSTRIDIUM DIFFICILE COLITIS 29
603 DEPENDENCE ON OXYGEN THERAPY 29
604 FACE INJURY 29
605 GASTROINTESTINAL PAIN 29
606 ILEUS 29
607 INJECTION SITE DISCHARGE 29
608 MENTAL DISORDER 29
609 NOCTURNAL DYSPNOEA 29
610 ORAL PAIN 29
611 PNEUMONIA BACTERIAL 29
612 SKIN DISORDER 29
613 VIRAL UPPER RESPIRATORY TRACT INFECTION 29
614 ATRIAL SEPTAL DEFECT 28
615 BLOOD DISORDER 28
616 COR PULMONALE 28
617 INJECTION SITE INDURATION 28
618 LIP SWELLING 28
619 RESTLESSNESS 28
620 BACK DISORDER 27
621 BLINDNESS 27
622 BLOOD LOSS ANAEMIA 27
623 COLONOSCOPY 27
624 DEAFNESS UNILATERAL 27
625 HAEMODYNAMIC INSTABILITY 27
626 INFUSION SITE BRUISING 27
627 INFUSION SITE VESICLES 27
628 INTESTINAL HAEMORRHAGE 27
629 LUNG OPERATION 27
630 MALNUTRITION 27
631 MATERNAL EXPOSURE DURING PREGNANCY 27
632 OLIGURIA 27
633 OSTEOMYELITIS 27
634 PRODUCT LEAKAGE 27
635 SKIN BURNING SENSATION 27
636 SPINAL OPERATION 27
637 SPLENOMEGALY 27
638 TOOTH ABSCESS 27
639 CATHETER SITE RELATED REACTION 26
640 DELIRIUM 26
641 DEVICE RELATED SEPSIS 26
642 ENDOTRACHEAL INTUBATION 26
643 FIBROMYALGIA 26
644 GASTROINTESTINAL MOTILITY DISORDER 26
645 LARGE INTESTINE POLYP 26
646 LARYNGITIS 26
647 MINERAL SUPPLEMENTATION 26
648 PARANASAL SINUS DISCOMFORT 26
649 SENSATION OF FOREIGN BODY 26
650 SINUS HEADACHE 26
651 SPINAL FRACTURE 26
652 THROMBECTOMY 26
653 THROMBOSIS IN DEVICE 26
654 TOOTH INFECTION 26
655 VASCULAR DEVICE OCCLUSION 26
656 ACUTE RESPIRATORY DISTRESS SYNDROME 25
657 ANAL INCONTINENCE 25
658 BLOOD ALKALINE PHOSPHATASE INCREASED 25
659 CATARACT OPERATION 25
660 CATHETER SITE IRRITATION 25
661 DEVICE PHYSICAL PROPERTY ISSUE 25
662 GASTRIC INFECTION 25
663 HIP ARTHROPLASTY 25
664 INCREASED APPETITE 25
665 INFUSION SITE CELLULITIS 25
666 INTENSIVE CARE 25
667 MIDDLE EAR EFFUSION 25
668 NIGHT SWEATS 25
669 PLASMA CELL MYELOMA 25
670 PRURITUS GENERALISED 25
671 PSORIASIS 25
672 RHINOVIRUS INFECTION 25
673 THIRST 25
674 VENTRICULAR TACHYCARDIA 25
675 WEIGHT ABNORMAL 25
676 ACUTE MYOCARDIAL INFARCTION 24
677 ANGIOEDEMA 24
678 CARDIOVASCULAR DISORDER 24
679 CARDIOVERSION 24
680 CATHETER SITE VESICLES 24
681 FULL BLOOD COUNT ABNORMAL 24
682 GASTROINTESTINAL INFECTION 24
683 HYPOPNOEA 24
684 HYPOTHYROIDISM 24
685 INFUSION SITE DISCOLOURATION 24
686 INJECTION SITE RASH 24
687 INTERVERTEBRAL DISC PROTRUSION 24
688 IRON DEFICIENCY 24
689 KNEE ARTHROPLASTY 24
690 LACERATION 24
691 OSTEOPOROSIS 24
692 PERIORBITAL SWELLING 24
693 PHARYNGITIS 24
694 PRODUCT DISTRIBUTION ISSUE 24
695 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 24
696 RESPIRATORY RATE INCREASED 24
697 SCAB 24
698 SCRATCH 24
699 ULCER HAEMORRHAGE 24
700 ACCIDENTAL EXPOSURE TO PRODUCT 23
701 APHONIA 23
702 CARDIAC DYSFUNCTION 23
703 CARPAL TUNNEL SYNDROME 23
704 CHOLECYSTITIS 23
705 EMPHYSEMA 23
706 PAINFUL RESPIRATION 23
707 PHARYNGITIS STREPTOCOCCAL 23
708 PULMONARY ANGIOPLASTY 23
709 SICKLE CELL ANAEMIA 23
710 TOOTH DISORDER 23
711 WRONG DOSE 23
712 CARBON DIOXIDE INCREASED 22
713 CARDIAC FAILURE HIGH OUTPUT 22
714 CHROMATURIA 22
715 EAR CONGESTION 22
716 ECHOCARDIOGRAM ABNORMAL 22
717 EPIGASTRIC DISCOMFORT 22
718 EYE IRRITATION 22
719 FACIAL BONES FRACTURE 22
720 HERNIA REPAIR 22
721 MITRAL VALVE INCOMPETENCE 22
722 OCULAR DISCOMFORT 22
723 PULMONARY ARTERIAL PRESSURE ABNORMAL 22
724 SKIN INFECTION 22
725 SUDDEN DEATH 22
726 SWOLLEN TONGUE 22
727 THINKING ABNORMAL 22
728 AMMONIA INCREASED 21
729 BODY TEMPERATURE INCREASED 21
730 CONCUSSION 21
731 CYST 21
732 ECZEMA 21
733 EMOTIONAL DISORDER 21
734 GLOMERULAR FILTRATION RATE DECREASED 21
735 HAEMORRHAGE INTRACRANIAL 21
736 HEAVY MENSTRUAL BLEEDING 21
737 INFUSION SITE EXTRAVASATION 21
738 INVESTIGATION 21
739 METABOLIC ACIDOSIS 21
740 NERVE COMPRESSION 21
741 RENAL PAIN 21
742 SENSITIVITY TO WEATHER CHANGE 21
743 SPINAL PAIN 21
744 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 21
745 TEMPERATURE INTOLERANCE 21
746 C-REACTIVE PROTEIN INCREASED 20
747 CARDIAC DISCOMFORT 20
748 CARDIAC VALVE DISEASE 20
749 DECUBITUS ULCER 20
750 DIPLOPIA 20
751 FACIAL PAIN 20
752 INCONTINENCE 20
753 INJECTION SITE BRUISING 20
754 INJECTION SITE WARMTH 20
755 INTERNATIONAL NORMALISED RATIO ABNORMAL 20
756 LIVER TRANSPLANT 20
757 LOWER GASTROINTESTINAL HAEMORRHAGE 20
758 MEDICATION ERROR 20
759 PULMONARY ARTERY THERAPEUTIC PROCEDURE 20
760 UTERINE LEIOMYOMA 20
761 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20
762 ACNE 19
763 APPLICATION SITE PRURITUS 19
764 ASPIRATION PLEURAL CAVITY 19
765 BRONCHOSPASM 19
766 CATHETER SITE INFLAMMATION 19
767 CORONARY ARTERY DISEASE 19
768 CORONAVIRUS INFECTION 19
769 DEPRESSED LEVEL OF CONSCIOUSNESS 19
770 DEVICE ADHESION ISSUE 19
771 END STAGE RENAL DISEASE 19
772 GALLBLADDER OPERATION 19
773 HAEMORRHAGIC DIATHESIS 19
774 HAND FRACTURE 19
775 INCORRECT DOSAGE ADMINISTERED 19
776 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19
777 INFUSION SITE NODULE 19
778 INFUSION SITE OEDEMA 19
779 INJECTION SITE IRRITATION 19
780 LOCAL SWELLING 19
781 NERVOUS SYSTEM DISORDER 19
782 PARKINSON^S DISEASE 19
783 RESPIRATORY TRACT INFECTION VIRAL 19
784 TACHYPNOEA 19
785 TOXICITY TO VARIOUS AGENTS 19
786 UPPER RESPIRATORY TRACT CONGESTION 19
787 VARICOSE VEIN 19
788 ADVERSE REACTION 18
789 APPENDICITIS 18
790 CARDIAC TAMPONADE 18
791 COLITIS ULCERATIVE 18
792 COMPRESSION FRACTURE 18
793 CROHN^S DISEASE 18
794 DEVICE USE ISSUE 18
795 DRY EYE 18
796 FAECES HARD 18
797 FOOD REFUSAL 18
798 FRUSTRATION TOLERANCE DECREASED 18
799 HELICOBACTER INFECTION 18
800 INGUINAL HERNIA 18
801 INSURANCE ISSUE 18
802 JUGULAR VEIN DISTENSION 18
803 LIVER FUNCTION TEST ABNORMAL 18
804 LOWER RESPIRATORY TRACT CONGESTION 18
805 MACULAR DEGENERATION 18
806 MECHANICAL VENTILATION 18
807 MICTURITION URGENCY 18
808 MUSCLE ATROPHY 18
809 MUSCULOSKELETAL DISORDER 18
810 OESOPHAGEAL PAIN 18
811 OESOPHAGEAL ULCER 18
812 ORAL CANDIDIASIS 18
813 ORAL DISCOMFORT 18
814 PAIN OF SKIN 18
815 QUALITY OF LIFE DECREASED 18
816 RASH PAPULAR 18
817 RHINITIS 18
818 SKIN HAEMORRHAGE 18
819 SUICIDAL IDEATION 18
820 THERAPEUTIC RESPONSE UNEXPECTED 18
821 TRAUMATIC FRACTURE 18
822 VITREOUS FLOATERS 18
823 ABASIA 17
824 CARDIAC MURMUR 17
825 CARDIOPULMONARY FAILURE 17
826 CARDIORENAL SYNDROME 17
827 CHEMOTHERAPY 17
828 COGNITIVE DISORDER 17
829 DERMATITIS 17
830 EAR DISORDER 17
831 EJECTION FRACTION DECREASED 17
832 ENERGY INCREASED 17
833 GROIN PAIN 17
834 HYPOAESTHESIA ORAL 17
835 LUNG INFILTRATION 17
836 MASS 17
837 NEEDLE ISSUE 17
838 PERIPHERAL VENOUS DISEASE 17
839 PHOTOPSIA 17
840 POLYP 17
841 RETINAL DETACHMENT 17
842 RIGHT VENTRICULAR ENLARGEMENT 17
843 SICKLE CELL DISEASE 17
844 SINUS PAIN 17
845 SYSTEMIC SCLERODERMA 17
846 TOOTH FRACTURE 17
847 TROPONIN INCREASED 17
848 VISUAL ACUITY REDUCED 17
849 WOUND INFECTION 17
850 ABDOMINAL CAVITY DRAINAGE 16
851 ABDOMINAL HERNIA 16
852 BLOOD ELECTROLYTES DECREASED 16
853 CARDIAC OUTPUT INCREASED 16
854 CATHETER SITE EXTRAVASATION 16
855 CATHETERISATION CARDIAC ABNORMAL 16
856 ENDOCARDITIS 16
857 FACIAL PARALYSIS 16
858 FRACTURE 16
859 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16
860 GASTRIC POLYPS 16
861 GASTROINTESTINAL INFLAMMATION 16
862 HAEMOGLOBIN ABNORMAL 16
863 HYPERCAPNIA 16
864 HYPOVOLAEMIA 16
865 INFUSION SITE URTICARIA 16
866 JAUNDICE 16
867 LIVER INJURY 16
868 MUSCLE TWITCHING 16
869 NOCTURIA 16
870 ORAL HERPES 16
871 PULMONARY ARTERY OCCLUSION 16
872 SKIN LESION 16
873 SUFFOCATION FEELING 16
874 TENDERNESS 16
875 ALTERED STATE OF CONSCIOUSNESS 15
876 ANURIA 15
877 AORTIC STENOSIS 15
878 APPETITE DISORDER 15
879 APPLICATION SITE ERYTHEMA 15
880 ARTERIOVENOUS MALFORMATION 15
881 BLOOD GLUCOSE ABNORMAL 15
882 BLOOD POTASSIUM ABNORMAL 15
883 BURSITIS 15
884 CARDIAC OUTPUT DECREASED 15
885 CERVICAL VERTEBRAL FRACTURE 15
886 CHOLECYSTITIS ACUTE 15
887 CONCOMITANT DISEASE PROGRESSION 15
888 DEVICE PLACEMENT ISSUE 15
889 DISCOURAGEMENT 15
890 EJECTION FRACTION ABNORMAL 15
891 EYE CONTUSION 15
892 EYE DISCHARGE 15
893 EYE OPERATION 15
894 GASTRIC CANCER 15
895 GASTRIC DILATATION 15
896 GASTROINTESTINAL SOUNDS ABNORMAL 15
897 GLAUCOMA 15
898 HEPATIC CANCER 15
899 HEPATIC STEATOSIS 15
900 HYPERGLYCAEMIA 15
901 IMMUNE SYSTEM DISORDER 15
902 INABILITY TO AFFORD MEDICATION 15
903 INCORRECT DRUG ADMINISTRATION RATE 15
904 INFUSION SITE MASS 15
905 INJECTION SITE REACTION 15
906 LABILE BLOOD PRESSURE 15
907 LEFT VENTRICULAR DYSFUNCTION 15
908 MUSCLE FATIGUE 15
909 NASAL OBSTRUCTION 15
910 NEPHROPATHY 15
911 NO THERAPEUTIC RESPONSE 15
912 NODULE 15
913 OTORRHOEA 15
914 PHOTOSENSITIVITY REACTION 15
915 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 15
916 SHOCK HAEMORRHAGIC 15
917 SKIN WARM 15
918 TREATMENT FAILURE 15
919 ABDOMINAL RIGIDITY 14
920 ABDOMINAL TENDERNESS 14
921 ABNORMAL FAECES 14
922 ARTHROPOD BITE 14
923 ASTHENOPIA 14
924 ATRIAL TACHYCARDIA 14
925 AUTOIMMUNE DISORDER 14
926 BLADDER DISORDER 14
927 BLOOD ALBUMIN DECREASED 14
928 BLOOD BLISTER 14
929 BLOOD CALCIUM DECREASED 14
930 CARDIAC SEPTAL DEFECT 14
931 CENTRAL VENOUS CATHETER REMOVAL 14
932 CRITICAL ILLNESS 14
933 DEFAECATION URGENCY 14
934 DIALYSIS HYPOTENSION 14
935 DISABILITY 14
936 DIVERTICULUM 14
937 EYE INFECTION 14
938 FAILURE TO THRIVE 14
939 FEELING OF BODY TEMPERATURE CHANGE 14
940 FLUID INTAKE REDUCED 14
941 HAEMATOCRIT INCREASED 14
942 HAEMODIALYSIS 14
943 HAEMORRHAGE URINARY TRACT 14
944 IMPAIRED HEALING 14
945 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 14
946 KNEE OPERATION 14
947 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 14
948 LUNG OPACITY 14
949 METASTASES TO LIVER 14
950 MYOCARDIAL NECROSIS MARKER INCREASED 14
951 NEUTROPENIA 14
952 OBESITY 14
953 OBSTRUCTIVE AIRWAYS DISORDER 14
954 PANCREATIC CYST 14
955 PELVIC FRACTURE 14
956 PETECHIAE 14
957 PLATELET COUNT INCREASED 14
958 PNEUMONIA VIRAL 14
959 PROCEDURAL HYPOTENSION 14
960 PRODUCT PREPARATION ISSUE 14
961 PRODUCT USE COMPLAINT 14
962 PULSELESS ELECTRICAL ACTIVITY 14
963 RENAL FUNCTION TEST ABNORMAL 14
964 RENAL INJURY 14
965 THYROID MASS 14
966 TRANSPLANT 14
967 ANIMAL BITE 13
968 APPLICATION SITE PAIN 13
969 BLADDER CANCER 13
970 BLADDER CATHETERISATION 13
971 BREAST PAIN 13
972 CHRONIC LEFT VENTRICULAR FAILURE 13
973 CONJUNCTIVAL HAEMORRHAGE 13
974 CREPITATIONS 13
975 DIASTOLIC DYSFUNCTION 13
976 DIURETIC THERAPY 13
977 DRUG ERUPTION 13
978 DRUG-INDUCED LIVER INJURY 13
979 EMBOLISM 13
980 ENTEROCOLITIS 13
981 EYELID OEDEMA 13
982 HAEMORRHAGE SUBCUTANEOUS 13
983 HEPATIC ENCEPHALOPATHY 13
984 HYPOKINESIA 13
985 INCORRECT DRUG ADMINISTRATION DURATION 13
986 INFARCTION 13
987 INFUSION RELATED REACTION 13
988 LEUKAEMIA 13
989 LIP INJURY 13
990 MUCOUS STOOLS 13
991 OCCULT BLOOD POSITIVE 13
992 OCULAR ICTERUS 13
993 OVARIAN CYST 13
994 PARAESTHESIA ORAL 13
995 PRODUCT PHYSICAL ISSUE 13
996 PROTHROMBIN TIME PROLONGED 13
997 PSEUDOMONAS INFECTION 13
998 RAYNAUD^S PHENOMENON 13
999 RENAL CANCER 13